In this issue (6 articles)

1. 

   Original Article

   Interaction of D₃ preferring agonist (−)-N ⁶-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N ⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264) with cloned human D_2L, D_2S, and D₃ receptors: potent stimulation of mitogen-activated protein kinases and G protein-coupled inward rectifier potassium channels

   Eldo V. Kuzhikandathil, Samantha Cote… Pages 97-105

   Look Inside Get Access

2. Original Article

   Direct and indirect interactions of the dopamine D₃ receptor with glutamate pathways: implications for the treatment of schizophrenia

   Pierre Sokoloff, Ludovic Leriche, Jorge Diaz… Pages 107-124

   Download PDF (774KB) View Article

3. 

   Original Article

   Pergolide block of the cloned Kv1.5 potassium channels

   Imju Jeong, Bok Hee Choi, Sang June Hahn Pages 125-133

   Look Inside Get Access

4. 

   Review

   Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications

   Jan-Peter van Wieringen, Jan Booij… Pages 135-154

   Look Inside Get Access

5. 

   Review

   Dopamine D₃ receptor antagonism—still a therapeutic option for the treatment of schizophrenia

   Gerhard Gross, Karsten Wicke… Pages 155-166

   Look Inside Get Access

6. 

   Review

   Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders

   Christian Heidbreder Pages 167-176

   Look Inside Get Access